Heterozygous Familial Hypercholesterolemia (HeFH)

DBCOND0063124Blood CholesterolGenetic Diseases, Inborn

Heterozygous Familial Hypercholesterolemia (HeFH) is the indication for 15 drugs in DrugBank. It is covered by 30 curated, structured indications.

Also known as
Heterozygous Familial Hypercholesterolemia · Heterozygous Familial Hypercholesterolaemia · Familial Hypercholesterolemia - Heterozygous
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10E78.00SNOMED CT238079002MedDRA10017342UMLSC0342882

What you can answer from here — as of October 25, 2026

15Indicated drugsWith each drug's targets and mechanism
Listed above
30Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
39Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Heterozygous Familial Hypercholesterolemia (HeFH) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In